Electromed, Inc. (ELMD) — SEC Filings
Electromed, Inc. (ELMD) — 22 SEC filings. Latest: 8-K (Dec 18, 2025). Includes 7 8-K, 6 10-Q, 4 SC 13G/A.
View Electromed, Inc. on SEC EDGAR
Overview
Electromed, Inc. (ELMD) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Dec 18, 2025: Electromed, Inc. entered into a material definitive agreement on December 16, 2025. This filing also indicates the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement for the registrant. The company is involved in the manufacturing of electromedical and
Sentiment Summary
Across 22 filings, the sentiment breakdown is: 2 bullish, 20 neutral. The dominant filing sentiment for Electromed, Inc. is neutral.
Filing Type Overview
Electromed, Inc. (ELMD) has filed 7 8-K, 6 10-Q, 1 DEF 14A, 2 10-K, 1 SC 13D/A, 4 SC 13G/A, 1 DEFA14A with the SEC between Feb 2024 to Dec 2025.
Filings by Year
Recent SEC Filings (22)
Risk Profile
Risk Assessment: Of ELMD's 17 recent filings, 0 were flagged as high-risk, 5 as medium-risk, and 12 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $16.89M |
| Net Income | $2.14M |
| EPS | $0.25 |
| Debt-to-Equity | 0.20 |
| Cash Position | $14.11M |
| Operating Margin | 15.8% |
| Total Assets | $53.61M |
| Total Debt | $8.87M |
Key Executives
- 500 Sixth Avenue NW New Prague , Minnesota 56071
- James L. Cunniff
- Bradley M. Nagel
- Board of Directors
- Personnel and Compensation Committee
- Nominating and Governance Committee
- Kathleen S. Skarvan
Industry Context
Electromed operates in the pulmonary care market, specifically focusing on High Frequency Chest Wall Oscillation (HFCWO) technology. The market is driven by the need for effective airway clearance solutions for patients with compromised pulmonary function. Key trends include the development of more user-friendly and technologically advanced devices, and increasing adoption in homecare settings.
Top Tags
10-Q (5) · financials (5) · quarterly-report (3) · Medical Devices (2) · SEC Filing (2) · 8-K (2) · disclosure (2) · Electromed (2) · Financial Report (2) · material-agreement (1)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| SEC File Number | 001-34839 | Identifies the company's filing with the SEC. |
| EIN | 41-1732920 | Employer Identification Number for Electromed, Inc. |
| Net Revenues | $16.89M | Increased by 15.1% from $14.67M year-over-year. |
| Net Income | $2.14M | Increased by 44.9% from $1.47M year-over-year. |
| Diluted EPS | $0.25 | Increased from $0.16 year-over-year. |
| Cash and Cash Equivalents | $14.11M | Decreased from $15.29M at June 30, 2025. |
| Selling, General and Administrative Expenses | $10.29M | Increased from $9.39M year-over-year. |
| Common Stock Repurchases | $1.00M | Amount spent under the new $10M authorization. |
| Effective Tax Rate | 23.8% | Decreased from 30.9% year-over-year. |
| Homecare Revenue | $14.89M | Primary driver of net revenue growth, up from $13.21M. |
| Number of directors | 8 | Proposed number of directors to be elected |
| Annual Meeting Date | 2025-11-14 | Date of the virtual Annual Meeting of Shareholders |
| Annual Meeting Time | 8:00 a.m. CST | Start time of the virtual Annual Meeting |
| Record Date | 2025-09-17 | Date for determining shareholders entitled to vote |
| Outstanding shares of common stock | 8,376,147 | Number of shares eligible to vote as of the record date |
Frequently Asked Questions
What are the latest SEC filings for Electromed, Inc. (ELMD)?
Electromed, Inc. has 22 recent SEC filings from Feb 2024 to Dec 2025, including 7 8-K, 6 10-Q, 4 SC 13G/A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of ELMD filings?
Across 22 filings, the sentiment breakdown is: 2 bullish, 20 neutral. The dominant sentiment is neutral.
Where can I find Electromed, Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Electromed, Inc. (ELMD) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Electromed, Inc.?
Key financial highlights from Electromed, Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for ELMD?
The investment thesis for ELMD includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Electromed, Inc.?
Key executives identified across Electromed, Inc.'s filings include 500 Sixth Avenue NW New Prague , Minnesota 56071, James L. Cunniff, Bradley M. Nagel, Board of Directors, Personnel and Compensation Committee and 2 others.
What are the main risk factors for Electromed, Inc. stock?
Of ELMD's 17 assessed filings, 0 were flagged high-risk, 5 medium-risk, and 12 low-risk.
What are recent predictions and forward guidance from Electromed, Inc.?
Forward guidance and predictions for Electromed, Inc. are extracted from SEC filings as they are enriched.